Product image of Letrozole Eugia (Letrozole) supplied by GNH India

Letrozole Eugia

Active Ingredient:
Letrozole
Origin:
EU

Letrozole Eugia (Letrozole)

Letrozole, the active ingredient in Letrozole Eugia, is an aromatase inhibitor presented as a tablet for oral use. It treats hormone receptor‑positive breast cancer in postmenopausal women by lowering estrogen levels, which can slow the growth of estrogen‑dependent tumors.

GNH India supplies Letrozole Eugia as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Manufacturer / TM Owner

Eugia Pharma (Malta) Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Letrozole Eugia is used in the management of estrogen‑dependent breast cancer, primarily in postmenopausal patients.

  • Hormone receptor‑positive breast cancer (postmenopausal): Reduces estrogen production to inhibit tumor growth.
  • Metastatic breast cancer (postmenopausal): Delays disease progression and improves survival.
  • Adjuvant therapy after surgery (postmenopausal): Decreases risk of cancer recurrence.

How It Works

  • Letrozole selectively inhibits the aromatase enzyme, which converts adrenal and peripheral androgens into estrogens. By blocking this conversion, systemic estrogen concentrations fall, reducing stimulation of estrogen‑dependent breast cancer cells and thereby limiting tumor proliferation.

Side Effects

Letrozole may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects

  • Hot flashes: Sudden feeling of warmth, often with sweating.
  • Joint and muscle pain: Arthralgia or myalgia affecting daily activities.
  • Fatigue: Persistent tiredness not relieved by rest.
  • Nausea: Mild to moderate upset stomach.
  • Headache: Intermittent pressure or throbbing pain.
  • Dizziness: Light‑headed sensation, especially when standing quickly.

Serious or Rare Side Effects

  • Severe liver injury: Jaundice, dark urine, elevated liver enzymes.
  • Bone fracture: Increased risk due to reduced bone mineral density.
  • Deep vein thrombosis or pulmonary embolism: Swelling, pain, or shortness of breath.
  • Severe allergic reaction: Rash, swelling, or difficulty breathing.
  • Elevated cholesterol: Significant changes in lipid profile.

Precautions & Warnings

When prescribing Letrozole Eugia, several safety considerations should be observed.

  • Pregnancy contraindication: Do not use in pregnant women; teratogenic risk (Category X).
  • Bone health monitoring: Assess bone mineral density periodically during therapy.
  • Liver function: Monitor hepatic enzymes regularly.
  • Lipid profile: Check cholesterol levels as alterations may occur.
  • Avoid in premenopausal women: Ineffective and may increase estrogen levels.
  • Store at ambient temperature: Keep in original container, protect from moisture.

Avoid Interactions

Letrozole can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Estrogen replacement therapy: Counteracts letrozole’s estrogen‑lowering effect.
  • Tamoxifen: Antagonistic action reduces therapeutic benefit.
  • Strong CYP2A6 inhibitors (e.g., ketoconazole): May increase letrozole exposure.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (e.g., rifampin): May lower plasma concentrations of letrozole.
  • Warfarin: Potential alteration of INR; monitor coagulation status.
  • Statins: Possible increased risk of myopathy; observe for muscle symptoms.

Frequently Asked Questions

Letrozole Eugia is prescribed for the treatment of hormone receptor‑positive breast cancer in postmenopausal women. It is used in both metastatic and adjuvant settings to lower estrogen levels, thereby slowing the growth of estrogen‑dependent tumor cells.

Letrozole blocks the aromatase enzyme, which is responsible for converting androgens into estrogens in peripheral tissues. By inhibiting this conversion, systemic estrogen concentrations fall, reducing the hormonal stimulus that drives the growth of certain breast cancers.

The specific dose of Letrozole Eugia is determined by the prescribing clinician based on the patient’s medical condition, treatment goals, and individual response. Dosage regimens are not standardized in public information and should follow the prescriber’s instructions.

Letrozole Eugia is classified as Pregnancy Category X, indicating it is contraindicated during pregnancy because it can cause fetal harm. It is also not recommended for breastfeeding mothers, as it may pass into breast milk and affect the infant.

To order Letrozole Eugia, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Letrozole is a third‑generation aromatase inhibitor with a high potency for suppressing estrogen production, often considered more effective than earlier agents such as anastrozole in certain clinical scenarios. Choice of agent depends on individual patient factors, tolerability, and physician preference.

Store Letrozole Eugia at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Letrozole Eugia is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed, unless otherwise directed by a healthcare professional.

Serious risks include severe liver injury, significant bone loss leading to fractures, and rare but life‑threatening events such as deep vein thrombosis or pulmonary embolism. Patients should report any signs of jaundice, unexplained bone pain, swelling of the limbs, or sudden shortness of breath to their clinician promptly.

Letrozole Eugia should not be used by pregnant or breastfeeding women, premenopausal patients, individuals with known hypersensitivity to letrozole, or patients with severe liver impairment. Clinicians should also exercise caution in patients with a history of osteoporosis or thromboembolic disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Letrozole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT